🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Ginkgo Bioworks Holdings, Inc. DNA R2K

Healthcare · Biotechnology · United States
https://www.ginkgo.bio

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. In addition, the company offers genetic medicine R&D, protein engineering, bioprocess development, crop nutrition and protection solutions, and plant trait optimization. The company serves pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

READ MORE ›
$9.37
+34.82% 1Y

Market & Price

Market Cap
$612.09M
Current Price
$9.37
High / Low (52W)
$16.14 / $5.48
Beta
1.78

Valuation

Stock P/E
-
Industry PE
23.65
Forward P/E
-
PEG Ratio
-
Book Value
$7.19
Price to Book
1.30
P/S
4.04
EV/EBITDA
-2.47
Dividend Yield
-

Profitability & Returns

ROCE
-30.63%
ROE
-56.03%
ROA
-16.16%
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-1.39
EPS (TTM)
$-5.38

Balance Sheet & Liquidity

Debt/Equity
0.93
Quick Ratio
4.95
Current Ratio
5.15
Debt
$410.70M
Total Assets
$1.12B
Current Assets
$471.84M
Working Capital
$375.87M

Ownership

Promoter Holding
4.60%
Chg in Prom Hold
-
FII / Inst Holding
68.65%
Chg in FII Hold
-0.01%

Financial Snapshot

Enterprise Value
$649.33M
Total Revenue (TTM)
$151.40M
EBITDA
$-262.49M
Free Cash Flow
$-77.93M
Operating Cash Flow
$-166.22M
Shares Outstanding
53.36M
Gross Margin
69.63%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
-29.11%
Profit 5Y
28.38%
Revenue (YoY)
-49.10%
Earnings (YoY)
-

PROS

  • Profit CAGR of 28.4% over 5 years.

CONS

  • Revenue declined at -29.1% CAGR over 5 years.
  • Trading 42.0% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 DNA Ginkgo Bioworks Holdings, Inc. R2K 9.37 - $612.09M - -30.63% -56.03% -29.11% 28.38%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
⚙Ad space

Quarterly Results

Figures in USD.

Metric Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 13.30M44.10M43.64M77.61M168.41M144.62M66.40M80.70M80.57M55.43M37.94M56.21M--38.23M49.60M38.84M33.40M19.47M
Cost of Revenue --------------4.09M14.82M12.80M7.30M3.10M
Gross Profit --------------34.14M34.78M26.04M26.09M16.38M
Operating Expenses --------------110.65M96.65M114.31M96.14M87.75M
Operating Income -34.41M-57.12M-59.95M-26.67M-675.37M-647.78M-654.94M-215.75M-184.15M-286.39M-178.00M-222.94M---76.51M-61.87M-88.27M-70.05M-71.37M
EBITDA ---------------61.68M-45.53M-74.10M-66.10M-58.58M
Interest Expense -------------------
Pretax Income ---------------83.22M-60.58M-80.75M-81.39M-76.14M
Tax Provision --------------88.00K-283.00K1.00K-643.00K-80.00K
Net Income -26.05M-73.57M-53.94M-101.88M-590.50M-668.83M-670.13M-204.97M-173.31M-302.89M--217.18M---90.96M-60.30M-80.75M-80.75M-82.59M
Diluted EPS ---0.04-0.08-0.37-0.41-0.41-0.11-0.09-6.21-3.32-4.23--2.00-1.68-1.10-1.45--1.39
R&D Expense 36.07M59.59M52.03M53.02M323.58M290.06M261.46M162.64M144.28M156.66M136.46M134.22M77.01M-70.92M53.37M69.35M-49.92M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 54.18M76.66M-477.71M251.46M227.04M170.16M
Cost of Revenue ---204.22M54.01M44.55M46.97M
Gross Profit ---273.49M197.45M182.50M123.18M
Operating Expenses ---2.48B965.65M670.22M427.06M
Operating Income -71.60M-137.03M--2.21B-768.20M-487.73M-303.88M
EBITDA ----2.08B-822.34M-484.39M-254.61M
Interest Expense ---106.00K93.00K94.00K0
Pretax Income ----2.12B-892.94M-547.51M-313.60M
Tax Provision ----15.03M-71.00K-479.00K-837.00K
Net Income -119.33M-126.61M--2.10B-892.87M-547.03M-312.76M
Diluted EPS -0.10-0.10--50.00-18.37-10.54-5.64
R&D Expense 96.30M159.77M1.15B1.05B580.62M424.06M243.77M

Compounded Sales Growth

5 Years:-29.11%
1 Year:-49.10%

Compounded Profit Growth

5 Years:28.38%
1 Year:-

Stock Price Performance

1 Year:+34.82%
6 Months:+7.58%
3 Months:+38.81%
1 Month:+24.93%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --675.15M-2.54B1.67B1.38B1.12B
Current Assets ----1.45B1.00B602.74M471.84M
Cash & Equivalents -495.29M380.80M-1.32B944.07M561.57M167.20M
Inventory ---3.36M4.36M46.00K--
Receivables ----82.47M17.16M21.86M24.03M
Total Liabilities --205.10M-803.04M568.19M661.39M611.11M
Current Liabilities --73.22M-172.96M163.86M107.27M95.97M
Long Term Debt --------
Total Debt ----442.59M239.31M467.73M439.88M
Total Equity 213.43M-461.38M-1.74B1.10B716.06M508.59M
Shares Outstanding ----47.30M50.03M54.37M58.21M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -44.66M-135.83M--252.20M-295.50M-319.58M-171.06M
Investing Cash Flow -74.60M-67.12M--67.39M-80.69M-62.24M-240.29M
Financing Cash Flow 410.38M90.32M-95.34M-3.22M-1.74M17.77M
Capital Expenditure -22.22M-57.82M--52.27M-40.80M-62.54M-7.67M
Free Cash Flow -66.88M-193.65M--304.47M-336.30M-382.13M-178.72M
Net Change in Cash ----224.25M-379.41M-383.56M-393.57M
Share Buybacks 408.00K------

Ratios (Annual)

Figures in %.

Metric Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---57.3%78.5%80.4%72.4%
Operating Margin % -132.1%-178.8%--462.4%-305.5%-214.8%-178.6%
Net Margin % -220.2%-165.2%--440.6%-355.1%-240.9%-183.8%
ROE % --27.4%--121.2%-81.4%-76.4%-61.5%
ROCE % --22.8%--93.3%-51.2%-38.4%-29.7%

Shareholding Pattern

Insiders
4.60%
Institutions
68.65%
Public Float
71.96%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 6.83% 3.64M $34.13M
2 Viking Global Investors, L.P. 6.70% 3.58M $33.52M
3 BAILLIE GIFFORD & CO 4.48% 2.39M $22.41M
4 Erste Asset Management GmbH 3.65% 1.95M $18.25M
5 Vanguard Capital Management LLC 3.59% 1.91M $17.94M
6 Anchorage Capital Group, LLC 3.27% 1.75M $16.36M
7 Legal & General Group PLC 3.11% 1.66M $15.57M
8 State Street Corporation 2.52% 1.35M $12.62M
9 Forbes, J.M. & Company 1.93% 1.03M $9.64M
10 Geode Capital Management, LLC 1.89% 1.01M $9.46M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for DNA

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space